Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols (Q33530732)

27 July 2017

Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols (English)

1 reference

27 July 2017

0 references

13

Peter Wipf

1 reference

27 July 2017

4

Diana Caridha

1 reference

27 July 2017

Erin Milner

1

1 reference

27 July 2017

William McCalmont

2

1 reference

27 July 2017

Jayendra Bhonsle

3

1 reference

27 July 2017

Jose Cobar

5

1 reference

27 July 2017

Sean Gardner

6

1 reference

27 July 2017

Lucia Gerena

7

1 reference

27 July 2017

Duane Goodine

8

1 reference

27 July 2017

Charlotte Lanteri

9

1 reference

27 July 2017

Victor Melendez

10

1 reference

27 July 2017

Norma Roncal

11

1 reference

27 July 2017

Jason Sousa

12

1 reference

27 July 2017

Geoffrey Stuart Dow

14

1 reference

27 July 2017

11 February 2010

1 reference

27 July 2017

1 reference

27 July 2017

9

1 reference

27 July 2017

51

1 reference

Creative Commons Attribution 2.0 Generic

27 July 2017

start time

11 February 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1475-2875-9-51

0 references

cites work

Structure-activity relationships amongst 4-position quinoline methanol antimalarials that inhibit the growth of drug sensitive and resistant strains of Plasmodium falciparum

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Utility of alkylaminoquinolinyl methanols as new antimalarial drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

The IPTi Consortium: research for policy and action

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Mefloquine induces dose-related neurological effects in a rat model

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

In silico prediction of blood–brain barrier permeation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Unexpected frequency, duration and spectrum of adverse events after therapeutic dose of mefloquine in healthy adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Drug-like properties and the causes of poor solubility and poor permeability

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

CNS drug design based on principles of blood-brain barrier transport

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

In vitro activities of and mechanisms of resistance to antifol antimalarial drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with dipalmitoylphosphatidylcholine bilayers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Drug-free holidays: pre-travel versus during travel malaria chemoprophylaxis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2833169

Thermodynamics of partitioning of the antimalarial drug mefloquine in phospholipid bilayers and bulk solvents

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20149249

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1475-2875-9-51

1 reference

Dimensions Publication ID

27 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1475-2875-9-51

9 September 2019

1 reference

27 July 2017

1 reference